Three COVID-19 Vaccines Developed in Thailand Are in Human Trials

 Three COVID-19 Vaccines Developed in Thailand Are in Human Trials

ChulaCov19 Vaccine by King Chulalongkorn Memorial Hospital. Photo: Chulalongkorn University.



BANGKOK (NNT) – The National Research Council of Thailand and National Vaccine Institute have revealed that more than 20 COVID-19 vaccines are being researched and developed in Thailand, while three candidates are undergoing human trials.

ChulaCov19, an mRNA vaccine developed by Chulalongkorn University, is in the first phase of human trials on 72 volunteers. Two doses of the vaccine were given at an interval of 21 days.

Full story: National News Bureau of Thailand

Reporter: Subhabhong Rarueysong,
Rewriter: Hugh Brammar
National News Bureau of Thailand



TN

The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

Related articles

Leave a Reply